ROTHBLATT MARTINE A (Chairperson & CEO) sold 2.8% of their position (9.50K shares) of UNITED THERAPEUTICS CORP on the open market
Open‑market sale worth $4.77M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+9.50K
Price / share
$117.76
Trade value
$1.12M
% of position
Common Stock
Shares
−120.00
Price / share
$498.44
Trade value
$59.81K
% of position
Common Stock
Shares
−1.79K
Price / share
$499.75
Trade value
$893.55K
% of position
Common Stock
Shares
−1.37K
Price / share
$500.58
Trade value
$686.80K
% of position
Common Stock
Shares
−2.24K
Price / share
$501.88
Trade value
$1.13M
% of position
Common Stock
Shares
−1.54K
Price / share
$502.80
Trade value
$772.30K
% of position
Common Stock
Shares
−578.00
Price / share
$503.76
Trade value
$291.17K
% of position
Common Stock
Shares
−702.00
Price / share
$505.03
Trade value
$354.53K
% of position
Common Stock
Shares
−600.00
Price / share
$505.94
Trade value
$303.56K
% of position
Common Stock
Shares
−280.00
Price / share
$506.76
Trade value
$141.89K
% of position
Common Stock
Shares
−280.00
Price / share
$508.80
Trade value
$142.47K
% of position
Net shares
+0.00
Net value
-$3.65M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/10/2026 | M · Option Exercise | +9.50K | $117.76 | $1.12M | 2.9% | 324.44K | 333.94K |
| Common Stock Indirect | 9/10/2026 | S · Sale | −120.00 | $498.44 | $59.81K | 0.0% | 333.94K | 333.82K |
| Common Stock Indirect | 9/10/2026 | S · Sale | −1.79K | $499.75 | $893.55K | 0.5% | 333.82K | 332.04K |
| Common Stock Indirect | 9/10/2026 | S · Sale | −1.37K | $500.58 | $686.80K | 0.4% | 332.04K | 330.66K |
| Common Stock Indirect | 9/10/2026 | S · Sale | −2.24K | $501.88 | $1.13M | 0.7% | 330.66K | 328.42K |
| Common Stock Indirect | 9/10/2026 | S · Sale | −1.54K | $502.80 | $772.30K | 0.5% | 328.42K | 326.88K |
| Common Stock Indirect | 9/10/2026 | S · Sale | −578.00 | $503.76 | $291.17K | 0.2% | 326.88K | 326.31K |
| Common Stock Indirect | 9/10/2026 | S · Sale | −702.00 | $505.03 | $354.53K | 0.2% | 326.31K | 325.60K |
| Common Stock Indirect | 9/10/2026 | S · Sale | −600.00 | $505.94 | $303.56K | 0.2% | 325.60K | 325K |
| Common Stock Indirect | 9/10/2026 | S · Sale | −280.00 | $506.76 | $141.89K | 0.1% | 325K | 324.72K |
| Common Stock Indirect | 9/10/2026 | S · Sale | −280.00 | $508.80 | $142.47K | 0.1% | 324.72K | 324.44K |
| Total | +0.00 | -$3.65M | ||||||
Stock Option
Common Stock
9.50K shares
Shares
−9.50K
Strike price
117.76
Held after
461.41K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Indirect | Common Stock9.50K shares | 9/10/2026 | M · Option Exercise | −9.50K | 117.76 | — | 461.41K |
Common Stock
IndirectCommon Stock
IndirectCommon Stock
DirectCommon Stock
IndirectCommon Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 8.90K | Indirect |
| Common Stock | 166.00 | Indirect |
| Common Stock | 40.51K | Direct |
| Common Stock | 45.60K | Indirect |
| Common Stock | 249.11K | Indirect |
| Total | 344.29K | 40.51K direct·303.77K indirect |